Lysine acetylation sites in bovine foamy virus transactivator BTas are important for its DNA binding activity  by Chang, Rui et al.
Virology 418 (2011) 21–26
Contents lists available at ScienceDirect
Virology
j ourna l homepage: www.e lsev ie r.com/ locate /yv i roLysine acetylation sites in bovine foamy virus transactivator BTas are important for
its DNA binding activity
Rui Chang 1, Juan Tan 1, Fengwen Xu, Hongqi Han, Yunqi Geng, Yue Li, Wentao Qiao ⁎
Key Laboratory of Molecular Microbiology and Biotechnology (Ministry of Education), College of Life Sciences, Nankai University, Tianjin 300071, China
Key Laboratory of Microbial Functional Genomics (Tianjin), College of Life Sciences, Nankai University, Tianjin 300071, China⁎ Corresponding author at: College of Life Sciences, Na
Tianjin 300071, China. Fax: +86 22 23501783.
E-mail address: wentaoqiao@nankai.edu.cn (W. Qiao
1 These authors contributed equally to the work.
0042-6822/$ – see front matter © 2011 Elsevier Inc. Al
doi:10.1016/j.virol.2011.07.003a b s t r a c ta r t i c l e i n f oArticle history:
Received 1 December 2010
Returned to author for revision 3 June 2011
Accepted 7 July 2011
Available online 3 August 2011
Keywords:
p300
Bovine foamy virus
BTas
AcetylationCellular acetylation signaling is important for viral gene regulation, particularly during the transactivation of
retroviruses. The regulatory protein of bovine foamy virus (BFV), BTas, is a transactivator that augments viral
gene transcription from both the long terminal repeat (LTR) promoter and the internal promoter (IP). In this
study, we report that the histone acetyltransferase (HAT), p300, speciﬁcally acetylates BTas both in vivo and in
vitro. Further studies demonstrated that BTas acetylation markedly enhances its transactivation activity.
Mutagenesis analysis identiﬁed three lysines at positions 66, 109 and 110 in BTas that are acetylated by p300.
The K110R mutant lost its binding to BFV promoter as well as its ability to activate BFV promoter. The
acetylation of K66 and K109 may contribute to increased BTas binding ability. These results suggest that the
p300-acetylated lysines of BTas are important for transactivation of BFV promoters and therefore have an
important role in BFV replication.nkai University, 94 Weijin Rd.,
).
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Acetylation of core histone and non-histone proteins is a key
process in the regulation of diverse intracellular pathways, including
chromatin remodeling and modulation of protein functions (Chen et
al., 2001; Glozak et al., 2005; Sterner and Berger, 2000). Acetylation of
the protein substrates is catalyzed by histone acetyltransferases
(HATs), a large family of structurally and functionally related proteins,
including p300, CBP, and PCAF. Recent studies have shown that
cellular acetylation is one of the primary targets of viral proteins
during their life cycle, which affects gene expression of both virus and
the host (Caron et al., 2003; Col et al., 2002; Hottiger and Nabel, 2000).
The viral proteins of human immunodeﬁciency virus type 1 (HIV-1)
(Cereseto et al., 2005; Deng et al., 2000; Kiernan et al., 1999; Ott et al.,
1999), Human T-lymphotropic virus type 1 (HTLV-1) (Lodewick et al.,
2009), and the prototype foamy virus (PFV) (Bannert et al., 2004;
Bodem et al., 2007) are substrates of HATs, and acetylation leads to a
functional advantage for these viral proteins. In addition to retrovi-
ruses, viruses of other families (Gwack et al., 2001; Wang et al., 2000;
Zhang et al., 2006) are known to interact with different HATs. These
observations suggest that acetylation of the viral proteins is a
ubiquitous strategy for the regulation of virus replication.
Foamy viruses (FVs), also known as spumavirus, are complex
retroviruses in the Spumaretrovirinae subfamily of Retroviridae(Delelis et al., 2004; Linial, 1999). Unlike conventional retroviruses,
FVs bear a second promoter between Tas and the 3′-end of env,
termed the internal promoter (IP), in addition to the long terminal
repeat (LTR) (Linial, 1999). The FV Tas protein is the central regulator
in viral gene expression and the key switch between latent and lytic
infection (Meiering and Linial, 2002). The HATs p300 and PCAF
speciﬁcally interact with PFV Tas protein in vivo, resulting in
enhancement of Tas-dependent transcriptional activation (Bannert
et al., 2004). Subsequently, the Tas of both PFV and feline foamy virus
(FFV) is proposed to be acetylated by PCAF, leading to increased
promoter-binding ability (Bodem et al., 2007).
Bovine foamy virus (BFV) is a non-primate member of
Spumaretrovirinae that was isolated from cattle in 1983 (Johnson
et al., 1983). Genomic analyses revealed similar sequence proper-
ties between BFV and PFV. The BTas protein is the transactivator
that enhances viral transcription through binding to viral pro-
moters, and its response elements have been mapped (Tan et al.,
2010). BTas is a 249-amino acid regulator that contains one N-
terminal DNA-binding domain and one C-terminal activation
domain, and the dimerization is required for its transactivational
activity (Tan et al., 2008, 2010).
Whether BTas associates with HATs has not been thoroughly
investigated. In this paper, our data suggested that p300 speciﬁcally
acetylates BTas both in vivo and in vitro. p300 and BTas synergistically
activated the BFV LTR and IP promoters. Three lysines at positions 66,
109, and 110 in the binding domain of BTas are identiﬁed as sites for
p300-dependent acetylation. These lysines are essential to transacti-
vation and binding ability of BTas. Moreover, acetylation increases the
afﬁnity of wild-type BTas to its responsive DNA elements. In
22 R. Chang et al. / Virology 418 (2011) 21–26conclusion, we report the involvement of HATs and the signiﬁcance of
acetylated lysines in BTas-dependent transactivation of BFV.
Results
p300 acetylates BTas and regulates BTas-dependent transactivation
To investigate whether acetylation is relevant for BTas transactiva-
tion, we used a histone deacetylase inhibitor, trichostatin A (TSA) to
inhibit histone deacetylase, and found that BFV promoters were
stimulated by treating BTas transfected-cells with TSA. Moreover, BFV
replicated more efﬁciently in TSA-treated cells, suggesting that BTas
may interact with HATs or undergo acetylation itself (see Supple-
mentary 1 for details). To demonstrate whether HATs acetylate BTas
and which histone acetyltransferases are functional, 293T cells were
transfected with plasmids expressing BTas and HAT candidates (p300,
CBP, and GCN5). BTas was immunoprecipitated from the cell lysates,
separated by SDS-PAGE, and blotted with anti-acetyl lysine antibody
to detect acetylation modiﬁcation. The results suggest that p300, but
not CBP or GCN5, speciﬁcally acetylates BTas protein in vivo (Fig. 1A).
To conﬁrm that BTas is a substrate for p300, we performed in vitro
acetylation experiment using recombinant HAT domain (1077–1718
aa) of p300. As a positive control, histone H3 was strongly acetylated
by the p300 HAT domain (Fig. 1B). Using this in vitro assay system, the
recombinant His-tag BTas protein was incubated with p300 HAT and
Ac-CoA, and then analyzed for acetylation. The results indicated that
BTas is a substrate for the HAT activity of p300 and can be acetylated
by p300 in vitro (Fig. 1C).Fig. 1. BFV BTas is acetylated by histone acetyltransferase p300 in vivo and in vitro.
(A) p300 acetylates BTas in vivo. pCMV-BTas construct were transiently transfected into
293T cells with CBP, p300, GCN5, or an empty vector. BTas protein was immunopre-
cipitated with rabbit anti-BTas antibody and immunoblotted with anti-acetylated
lysine antibody (upper panel). The same membrane was then striped and re-probed
with mouse anti-BTas antibody (lower panel). (B) In vitro acetylation of histone H3.
Histone H3 was incubated with p300 HAT domain or Ac-CoA, or both, at 37 °C for
60 min as indicated. Samples were then subjected to Western analysis using anti-
acetylated lysine antibody (upper panel). The histone H3 protein used in the assay was
detected by Coomassie blue staining (lower panel). (C) p300 acetylates BTas in vitro.
Puriﬁed His-tagged BTas was incubated with p300 HAT domain and Ac-CoA at 37 °C for
60 min. Samples were then subjected to Western blotting using anti-acetylated lysine
antibody (upper panel). The His-BTas protein used in the assay was detected by
Coomassie blue staining (lower panel).To examine the involvement of p300 in BTas-mediated transacti-
vation, 293T cells were co-transfected with pCMV-BTas, luciferase
expression plasmid driven by BFV LTR or IP, and increasing amounts of
p300. Luciferase activity was measured 48 h later. As shown in Fig. 2,
BTas-mediated activation of LTR and IP promoters were both
enhanced by p300 in a dose-dependent manner. Based on these
ﬁndings, we conclude that p300 is the functional acetyltransferase for
BTas acetylation, and that p300 and BTas can synergistically
transactivate BFV promoters.
Identiﬁcation of the lysine residues in BTas that are acetylated by p300
Next, we determined the speciﬁc sites of BTas that were acetylated
by p300. A series of BTas N-terminal deletions were expressed as GST-
BTas fusion proteins, and analyzed using in vitro HAT assay for their
acetylation (Fig. 3A). The results demonstrated that p300 efﬁciently
acetylates the D1 deletion mutant, whereas the D2 deletion mutant
was acetylated to a much lesser extent (the acetylation level was
approximately 25% of that observed with D1). The acetylation of D3
was, however, barely detectable (approximately 8% acetylation
compared to D1) (Fig. 3B, left panel, lane 4). Equivalent amounts of
substrate proteins were loaded in each lane as shown by Coomassie
blue staining (Fig. 3B, right panel). Taken together, the acetylation
targets of BTas recognized by p300 may locate in cluster 2 (62–89 aa)
and cluster 3 (90–113 aa). The lysine residues of these regions were
individually replaced by arginine and their potential to activate BFV
promoter were measured. The K66R, K74R, K109R and K110R
mutations led to impaired activation (see Supplementary 2 for
details). Lysines 109 and 110 were agreed with the “G/S K motif”Fig. 2. p300 synergizes with BTas to transactivate the BFV LTR and IP promoters.
(A) 293T cells were transfected with pCMV-BTas and pBFV LTR-Luc in the absence or
presence of increasing amounts of HA-p300. Cellular extracts were assayed for
luciferase activity at 48 h post-transfection. (B) The same experiment as in (A) was
carried out except for transfection with pBFV IP-Luc instead of pBFV LTR-Luc. The
results are representative of three independent transfections.
Fig. 3. Identiﬁcation of acetylated lysines in BTas. (A) Schematic representation of BTas N-terminal truncations. Lysines are indicated by black dots. (B) In vitro acetylation of BTas N-
terminal truncations by p300. Recombinant GST-tagged BTas N-terminal truncations, or GST were incubated with p300 HAT and Ac-CoA. The reactions were subjected to Western
analysis using anti-acetylated lysine antibody (left-hand) or Coomassie blue staining (right-hand). (C) Schematic representation of BTas point mutants at amino acid positions 66,
109, and 110. Lysines and arginines are indicated by black and gray dots, respectively. (D) In vitro acetylation of BTas lysine point mutants by p300 HAT. Recombinant wild-type His-
BTas and lysine point mutants were incubated with p300 HAT domain and Ac-CoA as described above. The reactions were subjected toWestern analysis using anti-acetylated lysine
antibody (upper panel) or Coomassie blue staining (lower panel). (E) The acetylation levels of His-BTas and lysine point mutants were quantiﬁed by ImageJ software and shown as
columns.
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p300-dependent acetylation by mass spectrometry (data not shown).
Taken together, these results indicated that K66, K109 and K110
maybe potential sites for p300-mediated acetylation.
To examine this hypothesis, lysines at amino acid positions 66,
109, and 110 were changed into arginines (Fig. 3C). These mutants
were incubated with p300 HAT and in vitro acetylation assays were
performed. The data revealed that p300 acetylates BTas when single
or double lysines were replaced by arginines (40% to 75% that of wild-
type) (Figs. 3D and E, lanes 3–8). The triple mutation (K66/109/110R),
however, completely abrogated p300-dependent acetylation (Figs. 3D
and E, lanes 2). This result conﬁrms that K66, K109, and K110 of BTas
are acetylated by p300.Acetylation of BTas increases its DNA-binding ability
Since acetylation is known to regulate the protein function, we
investigated whether acetylation of the three lysines is essential for
BTas nuclear translocation. We found that wild-type BTas and the
triple mutant both localized to the nucleus, suggesting that the three
lysines were not necessary for the nuclear import of BTas (see
Supplementary 3 for details).Further, since the acetylation of PFV and FFV Tas protein increase
their promoter-binding ability, we determined whether acetylation
was important for the DNA binding afﬁnity of BTas. To address this
issue, electrophoretic mobility shift assays (EMSA) were carried out.
As shown in Fig. 4A (left panel), increasing amounts of puriﬁed His-
tagged BTas were incubated with p300 HAT, and in vitro HAT assays
were performed. The acetylated and mock-acetylated BTas were then
incubated with a probe corresponding to the BFV LTR.TRE. The DNA–
protein complexes were analyzed by EMSA. As expected, a shifted
BTas-DNA complex was clearly detected at higher protein concentra-
tions (Fig. 4A, left panel, lane 4), whereas acetylated BTas bind to the
LTR at the modest protein concentration (Fig. 4A, left panel, lane 6).
The binding afﬁnity of acetylated BTas was elevated compared to their
counterparts in the unmodiﬁed BTas group (Fig. 4B and compare lanes
5–7 with lanes 2–4 in Fig. 4A, left panel). The GST protein was unable
to bind BFV LTR.TRE (Fig. 4A, right panel, lane 1), and the binding was
abolished when excess unlabeled LTR.TRE was added (Fig. 4A, right
panel, lane 3), demonstrating the speciﬁc interaction between BTas
and LTR. These results suggested that the DNA-binding property of
BTas was increased by p300-mediated acetylation. To further address
the requirement of BTas acetylation for DNA binding, wild-type His-
BTas or triple mutant were in vitro acetylated and tested for their
DNA-binding afﬁnity by EMSA. Acetylation enhanced BTas afﬁnity to
Fig.4. Acetylation of BTas promotes its DNA-binding ability. (A) Acetylation of wild-type BTas enhances DNA-binding afﬁnity. Increasing amounts of recombinant His-BTas (200 ng,
500 ng and 1 μg) were incubated with p300 HAT domain in the presence or absence of Ac-CoA and in vitro acetylation was carried out as described above. The acetylated and mock-
acetylated BTas were then incubated with digitonin-labeled BFV LTR.TRE and subjected to EMSA. The BTas and p300 HAT domain used in the assay were detected by Coomassie blue
staining and silver staining, respectively (lower panel). In the competition assay (right panel), GST was used as binding protein (lane 1), and His-BTas was incubated with BFV LTR in
the absence (lane 2) or presence (lane 3) of 20-fold excess of unlabeled BFV LTR. The GST and BTas protein used in the assay were detected by Coomassie blue staining (lower panel).
(B) The binding levels of BTas corresponding to each lane were quantiﬁed by ImageJ software, and indicated as columns. (C) Wild-type and triple lysine-substituted BTas were in
vitro acetylated or mock acetylated, then incubated with the BFV LTR.TRE probe and subjected to EMSA. The BTas and p300 HAT domain used in the assay were detected by
Coomassie blue staining and silver staining, respectively (lower panel). (D) BTas-dependent transactivation requires acetylated lysines. 293T cells were transfected with wild-type
BTas or the triple lysine mutant, in the presence of pBFV LTR-Luc or pBFV IP-Luc. Cellular extracts were examined for luciferase activity at 48 h post-transfection. The results are
representative of three independent transfections.
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of the BTas triple mutant to the DNA targets was completely abolished
(Fig. 4C, lane 4). Moreover, we found that wild-type BTas efﬁciently
transactivated LTR and IP promoters, while the triple mutation at K66,
K109, and K110 led to impaired transactivation (Fig. 4D). These data
illustrated that these lysines are necessary for BTas-mediated
transcription. Besides, acetylation of one or more of these residues
may be relevant to the enhancement of BTas DNA binding afﬁnity.
Acetylated lysines of BTas are important for DNA binding ability of BTas
We next investigated whether K66, K109 and K110 play a key role
in the binding of BTas to DNA. To this end, in addition to the triple-
lysine mutant as described above, the three lysines were changed to
arginine either individually or in combinations of two. DNA binding
ability of these mutants was measured by EMSA. The results showed
that mutation of K110, either individually or in combination of K66 or
K109, abrogated BTas/DNA interaction (Fig. 5A). We then performed
in vitro p300-mediated acetylation experiment to determine whether
acetylation of K66 and K109 contributes to BTas/DNA binding. The
results showed that acetylation of wild-type BTas increased its afﬁnity
for DNA (Fig. 5B, lane 3). Although the K66/109R mutant exhibited a
DNA binding ability similar to that of wild-type BTas (Fig. 5B, lane 4),
acetylation reaction did not increase the DNA afﬁnity of this mutant(Fig. 5B, lane 5). Together, our data demonstrate the key role of K110
in BTas/DNA interaction. Moreover, the enhancing effect of BTas
binding maybe partly results from the acetylation of K66/K109.
Discussion
The transactivator BTas is the central regulatory protein in BFV
replication, however, little is known about the mechanisms underlying
its regulation. In this study, we have used plasmid cotransfection assay,
in vitro acetylation assay and EMSA to investigate the role of acetylation
in BTas transactivation. Our data showed that p300 cooperates with
BTas to enhance the transactivation activity of the BFV LTR and IP
promoters. The acetylation of BTas can increase its DNA binding afﬁnity,
and the K66, K109, and K110 are critical residues for the DNA binding
ability of BTas. Thus, we hypothesized that acetylation of BTas protein
by p300 and the acetylated lysines of BTas are important in the
regulation of BTas-mediated transcription and virus–host interaction.
Recent investigations indicate that a number of viral proteins are
substrates for cellular histone acetyltransferase. For instance, the HIV-
1 transactivator Tat was acetylated by p300 at lysine 50, which
facilitates separation of the Tat-TAR complex and enhances transcrip-
tion of the integrated provirus (Kiernan et al., 1999). The acetylation
of HIV integrase by p300 increased its DNA-binding ability and
integration activity (Cereseto et al., 2005). In HTLV-1, the crosstalk
Fig.5. Acetylated lysines are important for DNA-binding ability of BTas. (A) Wild-type
and mono- or double-lysine-substituted BTas were incubated with BFV LTR.TRE and
subjected to EMSA. The proteins used in the assay were detected by Coomassie blue
staining (lower panel). (B) Wild-type BTas and K66/109R mutant were in vitro
acetylated or mock acetylated, then incubated with the BFV LTR.TRE probe and
subjected to EMSA. The BTas and p300 HAT domain used in the assay were detected by
Coomassie blue staining and silver staining, respectively (lower panel).
25R. Chang et al. / Virology 418 (2011) 21–26between Tax and p300 has a profound effect on activation of the NF-κB
signaling pathway (Lodewick et al., 2009). The Tas protein of PFV
functionally interacts with p300 and PCAF, and can be acetylated by
PCAF (Bannert et al., 2004; Bodem et al., 2007). Thus, our ﬁndings are
similar to the results obtained with these retroviruses. By contrast, two
members of the HAT family, GCN5 and CBP, do not acetylate BTas.
Therefore, it is possible that p300 is themost common acetyltransferase
used by retroviruses.
To date, there have been no reports regarding the acetylated sites
in FV Tas; thus, we set out to search for acetylated lysines in BTas by
p300-mediated acetylation. The three acetylated residues, K66, K109,
and K110, all locate in the binding domain (1–133 aa) of BTas, which
is consistent with the ﬁnding that p300 acetylates lysines in the
DNA/RNA-binding domain of HIV-1 integrase and Tat (Cereseto et al.,
2005; Deng et al., 2000; Kiernan et al., 1999; Ott et al., 1999).
Regulation by acetylating lysines in the binding domain is a
phenomenon observed in many cellular regulators (Martinez-Balbas
et al., 2000; Masumi et al., 1999; Thevenet et al., 2004). Of note, if a
lysine is preceded directly by a glycine, a serine or another lysine,
these two residues constitute the “G/SK motif”. The latter lysine, in
some cases, served as potential site for p300-dependent acetylation
(Bannister et al., 2000; Wolf et al., 2002). Not all of the acetylated
lysines exhibit the G/SK sequence. However, the K109 and K110 of
BTas are indeed found in such a motif.
Acetylation affects a variety of protein functions, including DNA-
binding capability, transactivation ability, protein stability, subcellular
localization, and protein–protein interaction (Chen et al., 2001; Glozak
et al., 2005). Our current study revealed a synergistic activation of BFV
promoters by p300 and BTas. This result is consistent with the
observation that p300 promotes Tas and Tat-mediated transcription
in PFV andHIV-1 (Bannert et al., 2004; Ott et al., 1999). Previous studies
demonstrated that acetylation of FFV Tas increases its DNA binding,
while Tat was dissociated from TAR by K50-acetylation (Bodem et al.,
2007; Kiernan et al., 1999). In this paper, we showed that acetylationpromotes BTas DNA-binding ability, which was similar to FFV Tas. We
further found that the triple lysine mutant was unable to bind viral
promoter. We could not exclude the possibility that the substitution of
three lysines to arginines alters other functions, such as binding
property or conformation, of wild-type BTas. Thus, the mono- and
double-lysine mutants were tested in EMSA. The data demonstrated
that DNAbindingwas abrogating once K110wasmutated. It is probably
that the dissociation of the triple mutant with DNA was due to the
absence of K110. Further results conﬁrmed that the DNA binding ability
of K66/109R mutation was not signiﬁcantly enhanced by acetylation.
Based on these observations, we assume that the increased DNA
binding afﬁnity of BTas maybe partly dependent on the acetylation of
K66 and K109. In contrast, it is likely that the lysine at position 110 is
associated with the DNA binding property of BTas. Since the acetylation
of different lysines in Tat regulates different functions (Col et al., 2001;
Kiernan et al., 1999), themechanism of BTas acetylation at these lysines
needs further in-depth investigation.
In the present study, we demonstrated that the acetylation of BTas
by p300 facilitates its interaction with the BFV promoters, thus
recruiting transcriptional partners to activate viral transcription. This
ﬁnding suggests that acetylation is a ubiquitous mechanism adopted by
foamy viruses to regulate gene expression. The current study shed light
on virus–host interactions and the mechanisms of BFV replication
through deciphering the relationship between BTas and p300, aswell as
their interactions with the basal transcription machinery.
Materials and methods
Cell culture, virus, transfection and reporter gene assay
293T cells were maintained in Dulbecco's modiﬁed Eagle's medium
(Invitrogen) supplemented with 10% heat-inactivated fetal bovine
serum, 50 U/ml penicillin, and 50 μg/ml streptomycin sulfate. BFV
indicator cell line (BFVL) was established by transfection of BHK21 cells
with luciferase expression gene thatwas driven by the BFV LTRpromoter.
G418 was added to select resistant colonies. The virus titer of BFV was
measured by BFV LTR directing luciferase expression by coculture cells
infected with BFVL. All cells were cultured in 10% CO2 atmosphere at
37 °C. Bovine foamy virus 3026was isolated from peripheral lymphoid of
a BIV seropositive cattle by our lab (Liu et al., 1997).
Transfection was performed by using polyethyleneimine (Sigma)
(Durocher et al., 2002) and corresponding plasmids. Transfection of
pCMV β-gal was carried out for normalization of transfection efﬁciency.
Cells were lysed and luciferase activity was measured 48 h post-
transfection according to the manufacturer's protocol (Promega). All
the transfection experiments were carried out at least three times.
Plasmids and recombinant proteins
pCMV-BTas, pBFV LTR-Luc and pBFV IP-Luc have been described
previously (Liu et al., 1999; Zhang et al., 2000). The histone
acetyltransferase expression plasmid HA-p300, CBP and GCN5 were
obtained from Upstate. The sequence coding for the C-termini of BTas
(amino acids 62 to 249, 90 to 249 and 114 to 249) were generated by
PCR using pCMV-BTas as template. The products were cloned into
pGEX-6p-1(Amersham Biosciences) vector to construct GST-tagged
BTas truncations. The plasmid for expression of His-BTas was
prepared by subcloning of BTas cDNA from pCMV-BTas into pET32a
vector (Novagen). The lysine mutants were generated by PCR-based
site directed mutagenesis (QuickChange Kit, Stratagene) using His-
BTas as template. The p300 HAT domain expression plasmid was
constructed by inserting a PCR-ampliﬁed fragment encoding amino
acids 1077–1718 of p300 cDNA into pGEX-6P-1 vector. All the new
constructs were veriﬁed by DNA sequencing.
Expression constructs for GST-p300 HAT, GST-tagged BTas trunca-
tions, His-tagged BTas and lysine mutants were transformed into E. coli
26 R. Chang et al. / Virology 418 (2011) 21–26strain BL21 (DE3). Puriﬁcation were carried out by glutathione-agarose
afﬁnity chromatography (Amersham Biosciences) or Ni-nitrilotriacetic
acid-agarose chromatography (Novagen) according to the manufac-
turer's protocols. Protein concentrations were determined by Bradford
method.
Antibodies and immunoprecipitation assay
Anti-acetylated-lysine mAb were purchased from Cell Signaling
Technology. The polyclonal antibody against BTas was prepared by
immunization of rabbit or mouse according to a standard procedure.
Immunoprecipitations were carried out using lysate prepared from
293T cells that were transfected with pCMV-BTas and different HATs
expression plasmids. Brieﬂy, 48 h after transfection, cells were
harvested and washed with ice cold PBS, lysed in 1 ml of lysis buffer
(50 mM Tris–HCl, pH 8.0, 150 mM NaCl, 1% NP-40, and 1 mM
phenylmethylsulfonyl ﬂuoride). After sonication, the cell debris was
removed by centrifugation at 10,000 g for 15 min at 4 °C. The
supernatant was incubated with rabbit anti-BTas antibody at 4 °C for
2 h. The immune precipitates were retrieved with 25 μl of Protein A-
Sepharose (50% slurry, Sigma-Aldrich) for another 2 h at 4 °C. Then
the immune complexes were washed six times with lysis buffer. The
immunocomplexes were boiled in 2×Laemmli sample buffer and
fractionated with 12% SDS-polyacrylamide gel, transferred to
Immobilon-P Transfer Membrane (Millipore), and blotted with
appropriate antibodies. Analysis of chemiluminescent signals was
performed with Western Blotting Luminol Reagent (Santa Cruz
Biotechnology). The intensity of bands was analyzed using ImageJ
software and corrected by subtracting the background noise.
In vitro acetylation assay
In vitro acetylation assays were performed using 1 μg of substrate
protein, 500 ng of bacteria puriﬁed p300 HAT domain, and 10 μM of
Ac-CoA (sigma) in HAT buffer (50 mM Tris–HCl, pH 7.5, 10% glycerol,
0.1 mM EDTA, 50 mM KCl, 10 mM sodium butyrate, 1 mM dithio-
threitol and 1 mM phenylmethylsulfonyl ﬂuoride). The proteins of
30 μl ﬁnal volume were incubated at 37 °C for 60 min. Samples were
then denatured in 2×Laemmli sample buffer and resolved by 12%
SDS-PAGE. The gels were stained with Coomassie brilliant blue or
subjected to Western blotting using anti-acetylated-lysine antibody.
Electrophoretic mobility shift assay
EMSA was carried out using DIG Gel Shift Kit (Roche). Brieﬂy,
oligonucleotide corresponding to BFV LTR.TRE −186 to −165 (5′-
ATAGCTATTTTAGTAAGTTAGC-3′) was synthesized and annealed with
the complementary strand. The puriﬁed native and acetylated BTas
were incubatedwith DIG-labeled probe in binding buffer for 20 min at
room temperature, the DNA–protein complexes were separated on 6%
non-denaturing polyacrylamide gel and subjected to visualization by
anti-digoxigenin-AP antibody according to the protocol.
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